New heart valve implant trial aims to stop dangerous leaks
Disease control
Not yet recruiting
This trial is testing a new device called the LuX-Valve Plus system to treat a severe leak in the heart's tricuspid valve. It will compare the new device to an existing one (EVOQUE) in 680 patients who have symptoms like shortness of breath and fatigue. The main goals are to see …
Phase: NA • Sponsor: Jenscare Innovation Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC